Skip to Content
U.S. National Institutes of Health
Cancer Diagnosis Program Cancer Imaging Program Cancer Therapy Evaluation Program Developmental Therapeutics Program Radiation Research Program Translational Research Program Biometric Research Branch Office of Cancer Complementary and Alternative Medicine
Last Updated: 04/25/2012


Since 2009, several clinical trial results reported findings that will likely change the way patients with acute myeloid leukemia (AML), multiple myeloma, breast cancer as well as children with high-risk neuroblastoma are treated. In addition, the discovery of certain gene alterations in children with acute lymphoblastic leukemia (ALL) has uncovered potential new targets for therapeutic approaches in this disease.